Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC Tech Council: ‘No Coast’ aims to prove landlocked doesn’t mean limited for local tech industry
Kansas City has been “punching above its weight” since the days of covered wagons, said Ryan Weber, noting the tech industry specifically has an impact of almost $11 billion a year on KC’s local economy. “Nationally, our profile has risen so much,” said Weber, president of the KC Tech Council which works to support the…
KC angels pile in with $2.74M funding raise for Matt Watson’s Stackify
A team of six local angel investors has pushed Kansas City-sourced Stackify past the $2 million mark in the company’s latest funding raise, Matt Watson announced Wednesday. “We are using the funds to continue our aggressive growth plans,” Watson, founder and CEO, said of the raise. Uploaded onto the startup scene in 2012, Stackify has…
Smart strategy generates wins for Evergy Ventures — KC’s quiet investment powerhouse
Editor’s note: The following content is sponsored by Evergy Ventures but independently produced by Startland News. As two long-standing utility companies merge, they’re creating a new kind of energy for GXP Investments — now known as Evergy Ventures — said Dennis Odell, announcing a rebrand of the investment firm. “GXP Investments — GXP — it…